Lineage Cell Therapeutics, Inc. (LCTX) Q1 2024 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (NYSE:LCTX) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET

Company Participants

Ioana Hone - Head, Investor Relations
Brian Culley - Chief Executive Officer
Jill Howe - Chief Financial Officer

Conference Call Participants

Jack Allen - Baird
William Wood - B. Riley
Joe Pantginis - H.C. Wainwright
Michael Okunewitch - Maxim Group
Sean McCutcheon - Raymond James

Operator

Welcome to the Lineage Cell Therapeutics First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available on the Investors section of Lineage website at www.lineage.com. This call is subject to copyright and is the property of Lineage and recordings for productions or transmissions of this call without the express written consent of Lineage are strictly prohibited. As a reminder, today's call is being recorded.

I would now like to introduce you to your host for today's call, Ioana Hone, Head of Investor Relations of Lineage. Ms. Hone, please go ahead.

Ioana Hone

Thank you, John. Good afternoon and thank you for joining us. A press release reporting our first quarter 2024 financial results was issued earlier today, May 9th, 2024, and can be found on the Investors section of our website.

Please note that today's remarks and responses to your questions reflect management's views as of today only and will contain forward-looking statements within the meaning of federal securities laws.

Statements made during this discussion that are not statements of historical fact should be considered forward-looking statements, which are subject to significant risks and uncertainties. The company's actual results or performance may differ materially from the expectations indicated by such forward-looking statements.

For a discussion of certain factors that could cause the company's results or performance to differ, we refer you to the forward-looking